Gastrointestinal cancer screening: screening may release new research funding to improve health service also in routine clinics

References

• Screening for colorectal cancer. Am Fam Physician 1989;40:40, 2, 5 passim.
   PubMed Web of Science ®Google Scholar
• GHoff. [Screening for cancer – a current health service? An updating of screening for breast cancer, cervix cancer and colorectal cancer]. Tidsskr Nor laegeforen 1987;107:1864–8; Screening for cancer – et aktuelt helsetilbud? En oppdatering av screening for kreft i bryst, livmorhals og tykktarm/endetarm.
   PubMedGoogle Scholar
• MBretthauer, GHoff. Comparative effectiveness research in cancer screening programmes. BMJ 2012;344:e2864.
   PubMed Web of Science ®Google Scholar
• JMGWilson, GJungner. Principles of practice of screening for disease. WHO, Geneva, Switzerland; 1968.
   Google Scholar
• JSMandel, TRChurch, JHBond, FEderer, MSGeisser, SJMongin, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603–7.
   PubMed Web of Science ®Google Scholar
• OKronborg, ODJorgensen, CFenger, MRasmussen. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004;39:846–51.
   PubMed Web of Science ®Google Scholar
• JHScholefield, SMoss, FSufi, CMMangham, JDHardcastle. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002;50:840–4.
   PubMed Web of Science ®Google Scholar
• WSAtkin, REdwards, IKralj-Hans, KWooldrage, ARHart, JMNorthover, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624–33.
   PubMed Web of Science ®Google Scholar
• RESchoen, PFPinsky, JLWeissfeld, LAYokochi, TChurch, AOLaiyemo, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345–57.
   PubMed Web of Science ®Google Scholar
• OHolme, MLoberg, MKalager, MBretthauer, MAHernan, EAas, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. Jama 2014;312:606–15.
   PubMed Web of Science ®Google Scholar
• NSegnan, PArmaroli, LBonelli, MRisio, SSciallero, MZappa, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial – SCORE. J Natl Cancer Inst 2011;103:1310–22.
   PubMed Web of Science ®Google Scholar
• MSherman. Hepatocellular carcinoma: screening and staging. Clin Liver Dis 2011;15:323–34; vii-x.
   PubMed Web of Science ®Google Scholar
• BHZhang, BHYang, ZYTang. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417–22.
   PubMed Web of Science ®Google Scholar
• JGChen, DMParkin, QGChen, JHLu, QJShen, BCZhang, et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 2003;10:204–9.
   PubMed Web of Science ®Google Scholar
• VPasechnikov, SChukov, EFedorov, IKikuste, MLeja. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol 2014;20:13842–62.
   PubMed Web of Science ®Google Scholar
• JFerlay, ESteliarova-Foucher, JLortet-Tieulent, SRosso, JWCoebergh, HComber, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in. 2012;Eur J Cancer 2013;49:1374–403.
   Web of Science ®Google Scholar
• DSchrag. The price tag on progress--chemotherapy for colorectal cancer. N Engl J Med 2004;351:317–19.
   PubMed Web of Science ®Google Scholar
• SWoloshin, LMSchwartz, WCBlack, BSKramer. Cancer screening campaigns--getting past uninformative persuasion. N Engl J Med 2012;367:1677–9.
   PubMed Web of Science ®Google Scholar
• PHSchwartz, EEdenberg, PRBarrett, SMPerkins, EMMeslin, TFImperiale. Patient understanding of benefits, risks, and alternatives to screening colonoscopy. Fam Med 2013;45:83–9.
   PubMed Web of Science ®Google Scholar
• OKronborg, CFenger, JOlsen, ODJorgensen, OSondergaard. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71.
   PubMed Web of Science ®Google Scholar
• JSMandel, JHBond, TRChurch, DCSnover, GMBradley, LMSchuman, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365–71.
   PubMed Web of Science ®Google Scholar
• JDHardcastle, JOChamberlain, MHRobinson, SMMoss, SSAmar, TWBalfour, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–7.
   PubMed Web of Science ®Google Scholar
• MFKaminski, MBretthauer, AGZauber, EJKuipers, HOAdami, Mvan Ballegooijen, et al. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012;44:695–702.
   PubMed Web of Science ®Google Scholar
• EQuintero, ACastells, LBujanda, JCubiella, DSalas, ALanas, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697–706.
   PubMed Web of Science ®Google Scholar
• JHDybdahl, KHaug, KBakkevold, KOOlsen, KVetvik. Screening for occult faecal blood loss in a community by means of Hemoccult II slides and a tetramethylbenzidine test. Scand J Gastroenterol 1984;19:343–9.
   PubMed Web of Science ®Google Scholar
• PMoayyedi, EAchkar. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol 2006;101:380–4.
   PubMed Web of Science ®Google Scholar
• EThiis-Evensen, GSHoff, JSauar, FLangmark, BMMajak, MHVatn. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414–20.
   PubMed Web of Science ®Google Scholar
• EThiis-Evensen, MKalager, MBretthauer, GHoff. Long-term effectiveness of endoscopic screening on incidence and mortality of colorectal cancer: a randomized trial. United European Gastroenterol J 2013;1:162–8.
   PubMed Web of Science ®Google Scholar
• GHoff, MVatn, EGjone, SLarsen, JSauar. Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study. Scand J Gastroenterol 1985;20:351–5.
   PubMed Web of Science ®Google Scholar
• GHoff, AFoerster, MHVatn, JSauar, SLarsen. Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. Scand J Gastroenterol 1986;21:853–62.
   PubMed Web of Science ®Google Scholar
• BHofstad, MHVatn, SNAndersen, HSHuitfeldt, TRognum, SLarsen, et al. Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut 1996;39:449–56.
   PubMed Web of Science ®Google Scholar
• PJPickhardt, DHKim, BDPooler, JLHinshaw, DBarlow, DJensen, et al. Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history. Lancet Oncol 2013;14:711–20.
   PubMed Web of Science ®Google Scholar
• WSAtkin, RValori, EJKuipers, GHoff, CSenore, NSegnan, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Colonoscopic surveillance following adenoma removal. Endoscopy 2012;44:SE151–63.
   PubMed Web of Science ®Google Scholar
• MLøberg, MKalager, ØHolme, GHoff, H-OAdami, MBretthauer. Long-term colorectal cancer mortality after adenoma removal. New Engl J Med 2014;371:799–807.
   PubMed Web of Science ®Google Scholar
• ELindholm, HBrevinge, EHaglind. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. British J Surg 2008;95:1029–36.
   PubMed Web of Science ®Google Scholar
• PHewitson, PGlasziou, EWatson, BTowler, LIrwig. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103:1541–9.
   PubMed Web of Science ®Google Scholar
• NMalila, TPalva, OMalminiemi, HPaimela, AAnttila, THakulinen, et al. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J Med Screen 2011;18:18–23.
   PubMed Web of Science ®Google Scholar
• MBretthauer, GGondal, KLarsen, ECarlsen, TJEide, TGrotmol, et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol 2002;37:568–73.
   PubMed Web of Science ®Google Scholar
• HBrevinge, ELindholm, SBuntzen, JKewenter. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years’ old population. Int J Colorectal Dis 1997;12:291–5.
   PubMed Web of Science ®Google Scholar
• MRasmussen, CFenger, OKronborg. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II. Scand J Gastroenterol 2003;38:114–18.
   PubMed Web of Science ®Google Scholar
• LHol, MEvan Leerdam, Mvan Ballegooijen, AJvan Vuuren, Hvan Dekken, JCReijerink, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62–8.
   PubMed Web of Science ®Google Scholar
• MHakama, GHoff, OKronborg, LPahlman. Screening for colorectal cancer. Acta Oncol (Madr) 2005;44:425–39.
   PubMed Web of Science ®Google Scholar
• PBoyle, PAutier, HBartelink, JBaselga, PBoffetta, JBurn, et al. European code against cancer and scientific justification: third version (2003). Ann Oncol 2003;14:973–1005.
   PubMed Web of Science ®Google Scholar
• PRozen, SJWinawer. Report of the OMED Colorectal Cancer Screening Committee Meeting, New Orleans, 2004 – in collaboration with the IDCA. Eur J Cancer Prev 2004;13:461–4.
   PubMedGoogle Scholar
• GHoff, JADominitz. Contrasting US and European approaches to colorectal cancer screening: which is best? Gut 2010;59:407–14.
   PubMed Web of Science ®Google Scholar
• GHoff. Different standards for healthy screenees than patients in routine clinics? World J Gastroenterol 2013;19:8527–30.
   PubMed Web of Science ®Google Scholar
• NMalila, AAnttila, MHakama. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screen 2005;12:28–32.
   PubMed Web of Science ®Google Scholar
• NMalila, TOivanen, OMalminiemi, MHakama. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008;337:a2261.
   PubMed Web of Science ®Google Scholar
• JBlom, SKilpelainen, RHultcrantz, STornberg. Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round. J Med Screen 2014;21:144–50.
   PubMed Web of Science ®Google Scholar
• PBerstad, MLoberg, IKLarsen, MKalager, OHolme, EBotteri, et al. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial. Gut 2014; [Epub ahead of print].
   PubMedGoogle Scholar
• MBretthauer, GHoff, EThiis-Evensen, TGrotmol, STHolmsen, VMoritz, et al. Carbon dioxide insufflation reduces discomfort due to flexible sigmoidoscopy in colorectal cancer screening. Scand J Gastroenterol 2002;37:1103–7.
   PubMed Web of Science ®Google Scholar
• MBretthauer, EThiis-Evensen, GHuppertz-Hauss, LGisselsson, TGrotmol, ESkovlund, et al. NORCCAP (Norwegian colorectal cancer prevention): a randomised trial to assess the safety and efficacy of carbon dioxide versus air insufflation in colonoscopy. Gut 2002;50:604–7.
   PubMed Web of Science ®Google Scholar
• MBretthauer, ABLynge, EThiis-Evensen, GHoff, OFausa, LAabakken. Carbon dioxide insufflation in colonoscopy: safe and effective in sedated patients. Endoscopy 2005;37:706–9.
   PubMed Web of Science ®Google Scholar
• GHoff, MBretthauer, GHuppertz-Hauss, EKittang, AStallemo, OHoie, et al. The Norwegian Gastronet project: Continuous quality improvement of colonoscopy in 14 Norwegian centres. Scand J Gastroenterol 2006;41:481–7.
   PubMed Web of Science ®Google Scholar
• RValori, JFRey, WSAtkin, MBretthauer, CSenore, GHoff, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Quality assurance in endoscopy in colorectal cancer screening and diagnosis. Endoscopy 2012;44:SE88–105.
   PubMed Web of Science ®Google Scholar
• MBretthauer, ESkovlund, TGrotmol, EThiis-Evensen, GGondal, GHuppertz-Hauss, et al. Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy screening for colorectal cancer. Scand J Gastroenterol 2003;38:1268–74.
   PubMed Web of Science ®Google Scholar
• IKLarsen, TGrotmol, MBretthauer, GGondal, GHuppertz-Hauss, BHofstad, et al. Continuous evaluation of patient satisfaction in endoscopy centres. Scand J Gastroenterol 2002;37:850–5.
   PubMed Web of Science ®Google Scholar
• WAtkin, PRogers, CCardwell, CCook, JCuzick, JWardle, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology 2004;126:1247–56.
   PubMed Web of Science ®Google Scholar
• JSint Nicolaas, Vde Jonge, RAde Man, Fter Borg, DLCahen, WMoolenaar, et al. The Global Rating Scale in clinical practice: a comprehensive quality assurance programme for endoscopy departments. Dig Liver Dis 2012;44:919–24.
   PubMedGoogle Scholar
• GHoff, MBretthauer, KGarborg, TJEide. New polyps, old tricks: controversy about removing benign bowel lesions. Bmj 2013;347:f5843.
   PubMed Web of Science ®Google Scholar
• OHolme, MBretthauer, TJEide, EMLoberg, KGrzyb, MLoberg, et al. Long-term risk of colorectal cancer in individuals with serrated polyps. Gut 2014. [Epub ahead of print].
   Web of Science ®Google Scholar
• DKRex, DJAhnen, JABaron, KPBatts, CABurke, RWBurt, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315–29. quiz 4, 30.
   PubMed Web of Science ®Google Scholar
• JLindebjerg, MOsler, CBisgaard. Colorectal cancers detected through screening are associated with lower stages and improved survival. Dan Med J 2014;61:A4758.
   PubMed Web of Science ®Google Scholar
• LKWanders, SCvan Doorn, PFockens, EDekker. Quality of colonoscopy and advances in detection of colorectal lesions: a current overview. Expert Rev Gastroenterol Hepatol 2014;1–14. [Epub ahead of print].
   Web of Science ®Google Scholar
• PDunckley, GElta. Quality assurance of training. Best Pract Res Clin Gastroenterol 2011;25:397–407.
   PubMed Web of Science ®Google Scholar
• FLoeve, RBoer, AGZauber, MVan Ballegooijen, GJVan Oortmarssen, SJWinawer, et al. National Polyp Study data: evidence for regression of adenomas. Int J Cancer 2004;111:633–9.
   PubMed Web of Science ®Google Scholar
• MGoetz. Real-time histology in colonoscopy. Gastroenterol Clin North Am 2013;42:567–75.
   PubMed Web of Science ®Google Scholar
• GHoff, MHVatn, SLarsen. Relationship between tobacco smoking and colorectal polyps. Scand J Gastroenterol 1987;22:13–16.
   PubMed Web of Science ®Google Scholar
• WSAtkin, AHart, REdwards, CFCook, JWardle, PMcIntyre, et al. Single blind, randomised trial of efficacy and acceptability of oral picolax versus self administered phosphate enema in bowel preparation for flexible sigmoidoscopy screening. Bmj 2000;320:1504–8; discussion 9.
   PubMed Web of Science ®Google Scholar
• SThomas-Gibson, PRogers, SCooper, RMan, MDRutter, NSuzuki, et al. Judgement of the quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates. Endoscopy 2006;38:456–60.
   PubMed Web of Science ®Google Scholar
• KKGarborg, MLoberg, JMatre, OHolme, MKalager, GHoff, et al. Reduced pain during screening colonoscopy with an ultrathin colonoscope: a randomized controlled trial. Endoscopy 2012;44:740–6.
   PubMed Web of Science ®Google Scholar